Stacchiotti, S., Trent, J. C., Somaiah, N., Chmielowski, B., Chugh, R., Fan, Z., Jones, R. L., Tine, B. A. V., Bui, N., Burgess, M. A., Chawla, S. P., Shen, Z., Vincenzi, B., Keedy, V. L., Pollack, S. M., Siontis, B. L. (2026). Phase 3 study (APROMISS) of catequentinib hydrochloride (AL3818) monotherapy in patients with advanced alveolar soft part sarcoma (ASPS).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.11502